Rinkey Investments’s Microbot Medical MBOT Stock Holding History

Rinkey Investments’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-500	Closed	-$3K	–	154
2021 Q4	$3K	Buy	+500	New	+$3.22K	﹤0.01%	212

Other funds holding MBOT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Rinkey Investments's MBOT Position: Q1 2022 in Review

Rinkey Investments sold out of Microbot Medical (MBOT) in Q1 2022, closing a stake of 500 shares — an estimated $3K sold.

Rinkey Investments first reported a position in MBOT in Q4 2021 and held it in 1 quarter. The position peaked at $3K in Q4 2021. 27 funds tracked by Wall St. Rank hold MBOT as of Q1 2022.

Rinkey Investments reported no remaining Microbot Medical position as of Q1 2022 after selling out during the quarter.
Rinkey Investments sold 500 Microbot Medical shares in Q1 2022, an estimated $3K.
Rinkey Investments first reported a position in Microbot Medical in Q4 2021 and held it in 1 quarter.
Rinkey Investments's Microbot Medical position peaked at $3K in Q4 2021.
27 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2022.

Based on Rinkey Investments's 13F filing for Q1 2022, filed 9 May 2022.